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T cell-mediated immunity requires T cell receptor
(TCR) cross-reactivity, themechanisms behindwhich
remain incompletely elucidated. The ab TCR A6
recognizes both the Tax (LLFGYPVYV) and Tel1p
(MLWGYLQYV) peptides presented by the human
class I MHC molecule HLA-A2. Here we found that
although the two ligands are ideal structural mimics,
they form substantially different interfaces with A6,
with conformational differences in the peptide, the
TCR, and unexpectedly, the MHC molecule. The
differences between the Tax and Tel1p ternary
complexes could not be predicted from the free
peptide-MHC structures and are inconsistent with
a traditional induced-fit mechanism. Instead, the
differences were attributable to peptide and MHC
molecularmotionpresent inTel1p-HLA-A2butabsent
in Tax-HLA-A2. Differential ‘‘tuning’’ of the dynamic
properties of HLA-A2 by the Tax and Tel1p peptides
thus facilitates cross-recognition and impacts how
structural diversity can be presented to and accom-
modated by receptors of the immune system.
INTRODUCTION
Recognitionof anantigenicpeptide-MHCcomplexbyanabTcell
receptor (TCR) initiates an intracellular signaling cascade leading
to a T cell response. Although antigen specificity is considered
a hallmark of cellular immunity, the TCR is cross-reactive, bind-
ing and responding to multiple peptide-MHC (pMHC) ligands.
Molecular mimicry, in which cross-reactive ligands share key
structural and chemical features (Kohm et al., 2003), is a mecha-
nism commonly used to explain TCR cross-reactivity. In prin-
ciple, molecular mimicry allows a single TCR to engage cross-
reactive ligands similarly. Yet molecular mimicry cannot easily
explain cross-reactive recognition of ligands with little or no
structural or chemical homology. A recently identified mecha-Inism facilitating such cross-recognition is the global reposition-
ing of a receptor on the surface of different ligands, allowing the
formation of stable interfaces despite imperfect homology (Colf
et al., 2007). Anothermechanism toexplain cross-reactive recog-
nition of dissimilar ligands involves conformational changes and
flexibility in the TCR complementary determining region (CDR)
loops, which can permit the TCR to adapt structurally to different
pMHC ligands (Gagnon et al., 2006; Mazza et al., 2007).
Yet in addition to the TCR, conformational shifts in both
peptide and MHC have been shown to occur upon TCR binding
(Garboczi et al., 1996; Ishizuka et al., 2008; Rudolph et al., 2001;
Tynan et al., 2007). Excluding the extensively bulged EPLP
peptide (Tynan et al., 2007), these shifts are frequently small
and usually interpreted as arising from ‘‘induced-fit’’ type confor-
mational adjustments. However, structurally observed confor-
mational shifts occurring upon protein binding can result from
inherent molecular flexibility (James et al., 2003; Lange et al.,
2008; Tobi and Bahar, 2005), and recent studies have shown
how subtle differences in class I MHC molecules can lead to
different peptide dynamics in MHC binding grooves (Archbold
et al., 2009; Fabian et al., 2008; Po¨hlmann et al., 2004). Given
the growing realization that even small amounts of flexibility
can profoundly influence molecular recognition, signaling, and
ultimately biological function (Smock and Gierasch, 2009),
a closer examination of the role of pMHC flexibility and its poten-
tial to influence immune recognition is warranted.
The human ab TCR A6 recognizes the HTLV-1 Tax peptide
(LLFGYPVYV) presented by the class I MHC molecule HLA-
A*0201 (HLA-A2). In addition to the Tax peptide, A6 also recog-
nizes the Saccharomyces cerevisiae peptide Tel1p (MLWGYL-
QYV). Tel1p was identified as a ligand for A6 after screening
databases for Tax-like peptides that matched the A6 recognition
motif (Hausmann et al., 1999). Cross-reactivity between Tax and
Tel1p is not unexpected given the similarities in the peptides.
However, differences in the fine specificity of A6 toward Tax
and Tel1p (Laugel et al., 2005) prompted us to examine the
recognition of the Tel1p ligand in greater detail. Surprisingly,
we found that although the free Tel1p-HLA-A2 complex is an
ideal structural mimic of the Tax ligand, the interface A6 forms
with Tel1p-HLA-A2 differs substantially from the interface itmmunity 31, 885–896, December 18, 2009 ª2009 Elsevier Inc. 885
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Figure 1. The Unligated Tel1p and Tax Complexes with HLA-A2 Are Sequence and Structural Mimics
(A) Sequences of the Tax and Tel1p peptides.
(B) Structure of the unligated Tel1p-HLA-A2 peptide-binding domain superimposed on the Tax-HLA-A2 peptide-binding domain. Superimposition is through the
backbones of the peptide-binding domains. The color code is given at the bottom of the figure and maintained in (C) and (D).
(C) Superimposition of the peptides from the free Tel1p-HLA-A2 structure and the free Tax-HLA-A2 structure.
(D) Superimposition of the peptides from the free Tel1p-HLA-A2 structure and the A6-Tax-HLA-A2 structure. Superimposition for all panels is by backbone
atoms.
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TCR Cross-reactivity via pMHC Flexibilityforms with Tax-HLA-A2, with differences in the peptide, the TCR
CDR3b loop, and unusually, the HLA-A2 a2 helix. The conforma-
tional differences between free and bound Tel1p-HLA-A2 and
the changes in the A6 CDR3b loop changes are interdependent,
indicating that TCR recognition of the Tel1p ligand requires the
mutual adaptation of both the TCR and the pMHC binding
surfaces. Notably, the conformational changes are inconsistent
with a purely induced-fit binding mechanism. Rather, in line
with emerging data on the influence of protein dynamics in
molecular recognition, molecular motion present in unligated
Tel1p-HLA-A2 but absent in unligated Tax-HLA-A2 was identi-
fied as the chief contributor to the differences between A6 recog-
nition of Tel1p and Tax, with the different degrees of flexibility
permitting the formation of different but equally complementary
TCR-pMHC interfaces. These findings shed light on how struc-
tural diversity can be presented to and accommodated by
receptors of the immune system and reveal that antigen-depen-
dent ‘‘tuning’’ of molecular motion distributed throughout the
TCR binding surface of the pMHC can contribute to TCR recog-
nition and facilitate cross-reactivity.
RESULTS
The Tel1p-HLA-A2 and Tax-HLA-A2 Complexes Are
Ideal Structural Mimics
We first determined the structure of the Tel1p-HLA-A2 complex
at 1.9 A˚ resolution (Figure 1). The complex crystallized isomor-
phously with the 1.8 A˚ Tax-HLA-A2 complex (Khan et al.,
2000). Data collection and refinement statistics are in Table 1;
electron density images are in Figure S1 available online. The
HLA-A2 heavy chain in Tel1p-HLA-A2 adopts the usual class I
MHC architecture, and the peptide binding domain superim-
poses onto that of the Tax-HLA-A2 structure with a backbone
rmsd of 0.3 A˚ (Figure 1). The N- and C-terminal regions of the
Tel1p and Tax peptides adopt similar conformations in the
peptide binding groove, and the side chains of Tyr5 and Tyr8
are superimposable (a water molecule was modeled adjacent
to Tyr5; we considered whether this could reflect an alternate
conformation for the Tyr5 side chain, yet the side chain and back-886 Immunity 31, 885–896, December 18, 2009 ª2009 Elsevier Inc.bone density in both traditional and omit maps as well as sterics
indicated the side chain position shown in Figure 1 was correct).
The backbones of the Tax and Tel1p peptides diverge at posi-
tions 6 and 7, but when the Tel1p peptide is compared to the Tax
peptide from the A6-Tax-HLA-A2 complex, in which the peptide
backbone is ‘‘squished’’ at positions 6 and 7 (Garboczi et al.,
1996), the backbones are in full alignment (the rmsd for superim-
position of all atoms of Tel1p onto all atoms of unligated Tax is
0.8 A˚; with ligated Tax the value is 0.4 A˚) (Figures 1B–1D).
Tel1p-HLA-A2 is thus an ideal structural mimic of Tax-HLA-A2.
Recognition of Tel1p-HLA-A2 Proceeds via
Conformational Changes in the Peptide, TCR, and MHC
We next determined the structure of the A6-Tel1p-HLA-A2
complex (Figure 2). The crystals diffracted to 2.7 A˚ resolution
and were of the same form as those of A6 bound to native Tax
and six Tax variants (Ding et al., 1999; Gagnon et al., 2006;
Garboczi et al., 1996; Piepenbrink et al., 2009). Data collection
and refinement statistics are in Table 1; electron density images
are in Figure S2. The binding mode of A6 on Tel1p-HLA-A2,
including the docking angle and tilt, is the same with Tel1p as
with Tax (Figure 2A). However, upon examining the TCR-
pMHC interface, differences were seen in the conformation of
the peptide, the TCR, and most unusually, HLA-A2 (Figure 2B).
A defining feature of the A6 TCR bound to the Tax peptide is
the ‘‘pocket’’ formed between the CDR3a and CDR3b loops
(Garboczi et al., 1996; Hausmann et al., 1999). In recognition of
the Tax peptide by A6, Tyr5 maintains the conformation seen in
the unbound pMHC and occupies this pocket. In the structure
with Tel1p, however, Tyr5 has moved away from its unbound
conformation and now points toward the HLA-A2 a2 helix
(Figure 2C). The movement occurs via a 100 rotation around
c1 and results in a 9.6 A˚ displacement of the tyrosine hydroxyl
(weak electron density was observed near the position the Tyr5
ring occupies in the Tax structure; this was modeled as a water
as both traditional and omit maps indicated stronger and more
complete side chain density for the position shown in Figure 2C).
Rotation of the Tel1p Tyr5 c1 angle is permitted by an 88 rota-
tion in the Tyr5 c bond (Figure 2C), which points the Tyr5
Table 1. X-Ray Data and Refinement Statistics
Protein Complex Tel1p-HLA-A2 A6-Tel1p-HLA-A2 Tel1p-HLA-A2 (A150P) Tax-HLA-A2 (A150P)
PDB entry 3H7B 3H9S 3H9H 3IXA
Radiation source APS 19BM APS 19BM APS 31ID APS 31ID
Space group P1 C2 P21 P21
a [A˚] 50.32 223.11 63.16 60.89
b [A˚] 63.06 48.31 88.89 85.29
c [A˚] 74.88 92.48 79.41 82.48
a [] 81.95 90 90 90
b [] 75.95 90.67 89.97 89.84
g [] 77.88 90 90 90
Molecules/a.u. 2 1 2 2
Resolution (A˚) 20–1.9 20–2.7 20–2.0 20–2.1
Total number of reflections 67,439 27,920 56,073 48,760
Mosaicity () 0.53 0.89 0.26 0.96
Completeness (%)a 96.8 (94.4) 99.4 (98.2) 97.3 (86.3) 97.1 (76.3)
I/s 13.5 (1.98) 17.7 (2.0) 18.0 (2.6) 19.4 (1.73)
Rmerge (%) 6.6 (35.6) 8.8 (45.3) 6.9 (31.6) 6.4 (43.1)
Average redundancy 1.9 (1.9) 3.5 (3.1) 3.6 (2.9) 3.5 (2.2)
Rwork (%) (no. reflections) 19.2 (64,026) 21.7 (25,991) 17.1 (53,214) 18.8 (46,274)
Rfree (%) (no. reflections) 24.2 (3,396) 28.9 (1,387) 22.6 (2,841) 23.0 (2,464)
Average B factor (all atoms) (A˚2) 26.2 62.8 36.5 23.2
Ramachandran plot
Most favored (%) 91.6 86.9 92.8 92.3
Allowed (%) 8 12.4 7 7.4
Generously allowed (%) 0.4 0.6 0.1 0.3
Rms deviations from ideality
Bonds (A˚) 0.016 0.013 0.016 0.017
Angles () 1.717 1.675 1.632 1.927
Coordinate error (A˚)b 0.13 0.33 0.12 0.14
aNumbers in parentheses refer to the highest-resolution shell.
bMean estimate based on maximum likelihood methods.
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Without this rotation, the movement in the side chain would be
prevented by an overlap with the carbonyl oxygen. After rotation
of the Tyr5 c bond, the path of the peptide is retained in an
extended conformation by an 89 counter-rotation of the Leu
6 f bond. Along with the rotation of Tyr5, the Tel1p Gln7 side
chain rotates by 62 around c1. This shifts the Gln7 side chain
away from Tyr5 by 2.4 A˚, probably to minimize repulsion
between the oxygen atoms of the side chains.
Along with the changes in the peptide, a surprising structural
reorganization in HLA-A2 occurs upon A6 recognition of Tel1p-
HLA-A2 (Figure 2D). The change occurs in and around the small
loop comprised of Ala150-Val152 that normally links the short
and long helical elements of the a2 helix. The change is best
summarized as a conformational ‘‘switch’’ that shortens the
short arm of the helix and extends the long arm of the helix,
such that Ala150, which is normally at the C terminus of the short
helix, now forms the N terminus of the long helix. Measured by
the position of its a carbon, Ala150 moves by 6.9 A˚. To accom-
modate its new N terminus, the long helix is displaced away
from the peptide and does not return to its normal position until
Gln155, one-third down the length of the long segment of the a2Ihelix. The short helical segment, rather than ending at Ala150,
now ends three residues earlier at Trp147. The switch in the a2
helix is necessary to accommodate the changes in the Tel1p
peptide: without the switch, overlap would occur between atoms
within the peptide and the a2 helix (Figure 2F).
Alongwith thechanges in thepeptide and theMHC, theCDR3b
loop of the A6 TCR in the A6-Tel1p-HLA-A2 complex is shifted up
and away from its position in the A6-Tax-HLA-A2 complex. The
shift is maximal at the Gly101b a carbon, resulting in a 4.5 A˚
displacement for the apex of CDR3b (Figure 2E). As with the
change in the MHC a2 helix, the shift in CDR3b is necessary to
accommodate the changes in the Tel1p peptide, in this case to
avoid steric clashes between atoms of the loop and Tyr5 (Fig-
ure 2F). The shift in CDR3b is similar to, albeit slightly smaller
than, the CDR3b shift seen upon A6 recognition of the bulky
Tax-5K-IBA peptide (Figure 3A; Gagnon et al., 2006), resulting
in a large distortion of the central pocket between the CDR3a
and CDR3b loops (Figure 3B). The other five CDR loops remain
in conformations similar to those seen in the Tax structure, with
maximum displacements of 1 A˚ for CDR3a and CDR2a.
The interfacial contacts in the A6-Tel1p-HLA-A2 structure are
significantly altered compared to the structure with Tax. Relativemmunity 31, 885–896, December 18, 2009 ª2009 Elsevier Inc. 887
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Figure 2. Recognition of Tel1p-HLA-A2 by the A6 TCR Proceeds with Changes in the Peptide, the TCR, and the HLA-A2 a2 Helix
The color code for all panels is given in the lower right of the figure.
(A) Overview of the A6-Tel1p-HLA-A2 and A6-Tax-HLA-A2 complexes.
(B) Cross-eyed stereo view highlighting the three major changes in the interface: peptide, TCR CDR3b, and HLA-A2 a2 helix.
(C) Close-up view of the changes that occur in the Tel1p peptide upon TCR binding. The rotations of the Tyr5 andGln7 side chains are indicated, as is the distance
moved and the compensating rotations in the Tyr5 c and the Leu6 f bonds. The clash that would occur between the Tyr5 side chain and the peptide backbone if
the backbone did not rotate is indicated in red.
(D) Close-up of the difference in the HLA-A2 a2 helix between the Tel1p and Tax complexes with A6. The differential position of the Ala150 a carbon in the two
complexes is indicated, and the shifting region of the helix is in red.
(E) Close-up of the difference in the A6 CDR3b loop between the Tel1p and Tax complexes with A6. The differential position of the a carbon of Gly101b in the two
complexes is indicated.
(F) The various conformational changes are mutually dependent. Steric clashes occur if the Tel1p peptide from the Tel1p ternary complex is fit into the peptide-
binding domain from the unligated Tel1p-HLA-A2 complex or into the A6-Tax-HLA-A2 interface. Clashes, defined as interatomic distances less than the sum of
the corresponding van der Waals radii, are shown as dashed red lines. Superimposition for all panels is through backbone atoms of the variable and peptide-
binding domains.
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TCR Cross-reactivity via pMHC Flexibilityto the Tax structure, with Tel1p there is a net loss of seven TCR-
pMHC hydrogen bonds, including three between CDR3b and the
HLA-A2 a2 helix. This includes a hydrogen bond to Gln155 of
HLA-A2, which has been proposed to serve as a minimal TCR
‘‘anchor’’ point on class I MHC molecules (Clements et al.,888 Immunity 31, 885–896, December 18, 2009 ª2009 Elsevier Inc.2006). The contacts to the a2 helix linker region are substantially
altered, and several amino acids that figure prominently in the
Tax interface participate in the Tel1p interface minimally or not
at all (a detailed comparison of the two interfaces is given in Fig-
ure S3). Notably, however, the shape complementarity between
CDR3β CDR3β
CDR1β CDR1β
CDR2β CDR2β
CDR3α CDR3α
CDR1α CDR1α
CDR2α CDR2α
A6–Tax-HLA-A2 A6–Tel1p-HLA-A2 A6–Tax-5K-IBA-HLA-A2
Tel1p Tax
A
B
Figure 3. Recognition of Tel1p by A6
Proceeds with Changes in the CDR3b Loop,
but Other Loops Are Largely Unaltered
(A) Cross-eyed stereo view of the CDR loop posi-
tions in the complexes of A6 with the Tel1p, Tax,
and Tax-5K-IBA peptides (color code is under
the panel). The view is through the peptide-binding
domain of HLA-A2, with the Tel1p peptide shown
inmagenta for reference. Compared to recognition
of the Tax peptide, the large shift in CDR3b upon
recognition of Tel1p is evident, and it is similar
but slightly smaller than the shift seen in recogni-
tion of Tax-5K-IBA (Gagnon et al., 2006).
(B) Comparison of the TCR central pocket in the
Tel1p (left) and Tax (right) ternary complexes. The
view is as in (A), with the surface of the TCR shown.
CDR3b is blue and CDR3a is yellow. Superimposi-
tion for both panels is by the backbones of the vari-
able domains.
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TCR Cross-reactivity via pMHC Flexibilitythe two interfaces is unchanged: both the A6-Tel1p-HLA-A2 and
A6-Tax-HLA-A2 interfaces have shape complementarity statis-
tics of 0.63 (Lawrence and Colman, 1993).
The reasons for the conformational differences between the
interfaces A6 forms with Tel1p-HLA-A2 and Tax-HLA-A2 are
not immediately apparent from examining the structures. This
is clear when the unligated structure of Tel1p-HLA-A2 is super-
imposed onto the structure of Tax-HLA-A2 in the A6-Tax-HLA-
A2 ternary complex. As shown in Figure S4, the steric clashes
that occur in this superimposition are not extensive and could
be eliminated by more subtle shifts of the side chains of
Gln155 of HLA-A2 and Gln7 and Tyr8 of the Tel1p peptide. There
are no crystallographic contacts to the centers of the peptides or
the region of the HLA-A2 a2 helix spanning amino acids 146–156
in any of the structures examined.
Altogether, the structural data indicate that A6 forms different
yet equally complementary interfaces with the Tel1p-HLA-A2
and Tax-HLA-A2 ligands. That this occurs despite a high degree
of structural and sequence homology between the unligated
pMHC complexes suggests the influence of a dynamic mecha-
nism not discernable from structure alone.
Mutagenesis Confirms the Switch in HLA-A2
and Suggests Coupling between Tel1p
and HLA-A2 Flexibility
Although small rigid body displacements of the class I MHC a1
and/or a2 helices have been previously observed to occur
upon TCR binding (Ishizuka et al., 2008; Rudolph et al., 2001),Immunity 31, 885–896, Dthe structural remodeling observed upon
A6 recognition of Tel1p-HLA-A2 was
unusual and unanticipated (Figure S5).
We thus sought to independently confirm
the conformational switch in the HLA-A2
a2 helix that occurs upon A6 recognition
of Tel1p-HLA-A2.
To do this, we took advantage of the
differential placement of Ala150 in the
structures of A6 bound to Tax and
Tel1p: in the A6-Tel1p-HLA-A2 structure,Ala150 is at the N terminus of a helical segment, whereas in the
A6-Tax-HLA-A2 structure, Ala150 is at the C terminus of a helical
segment (Figure 2E). As illustrated in Figure 4A, mutagenesis of
Ala150 to proline should therefore have opposing effects on the
binding of A6 to the complexes of Tax or Tel1p with HLA-A2. For
any position other than the N terminus, proline destabilizes an
a helix as the i/i4 hydrogen bond is lost and the carbons of
the proline ring clash with the preceding backbone. At a helix
N terminus, however, there is no requirement for an i/i4
hydrogen bond and there is no preceding helical geometry for
the proline side chain to interfere with. Also, proline is a strong
helix initiator and has a high statistical preference for helix N
termini (Kim and Kang, 1999). We thus hypothesized that substi-
tution of Ala150 with proline would (1) weaken TCR recognition
of the Tax peptide as the helical structure necessary for binding
is destabilized and (2) strengthen TCR recognition of the
Tel1p peptide as the helical structure necessary for binding is
stabilized.
Figure 4B shows the results of Biacore binding experiments for
A6 binding the Tax and Tel1p peptides presented by wild-type
and A150P HLA-A2. As hypothesized, the A150P mutation
weakens TCR affinity for Tax-HLA-A2, reducing the KD from 2
to 10 mM (equivalent to a DDG of 1.0 kcal/mol). Conversely,
the mutation strengthens TCR affinity for Tel1p-HLA-A2,
enhancing the KD from 41 to 5 mM (equivalent to a DDG
 of
1.2 kcal/mol). The differential effect of the A150P mutation
independently verifies the crystallographically observed confor-
mational switch in HLA-A2.ecember 18, 2009 ª2009 Elsevier Inc. 889
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Figure 4. Proline Mutagenesis Verifies the
Switch that Occurs in the HLA-A2 a2 Helix
upon A6 Recognition of the Tel1p Peptide
and Suggests Coupling between Motion in
the a2 Helix and the Tel1p Peptide
(A) Proline at position 150 would break the usual
HLA-A2 a2 helix conformation, as a hydrogen
bond is lost and interatomic bumps are introduced
(left; additional atoms from the proline ring are
yellow). In contrast, the altered conformation
seen in A6 recognition of the Tel1p peptide can
tolerate a proline at position 150 (right).
(B) Results for the A6 TCR binding wild-type or
A150Ppeptide-HLA-A2presenting theTaxpeptide
(left) or the Tel1ppeptide (right). Consistentwith the
structural data, the A150P mutation weakens
affinity for Tax but enhances affinity for Tel1p.
(C) The structures of the A150P HLA-A2 mutant
presenting the Tel1p and Tax peptide verify that
the mutation stabilizes the altered conformation.
The ‘‘normal’’ a2 helix conformation from the unli-
gated Tel1p complex is gray, the conformation
from the A6-Tel1p-HLA-A2 ternary complex is
cyan, the conformation from the unligated A150P
mutant with Tel1p is light brown, and the confor-
mation from the unligated A150P mutant with
Tax is burgundy. Superimposition is via backbone
atoms of the peptide-binding domains.
(D) Electron density for peptide side chains in the
A150P Tel1p structure (top) is weaker than the
density in the A150P Tax structure (bottom),
despite the fact that the Tel1p structure is of
slightly better resolution. This suggests a coupling
between mobility in the Tel1p peptide and mobility
in the HLA-A2 a2 helix. Densities are sA weighted
2FoFc contoured at 1s.
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TCR Cross-reactivity via pMHC FlexibilityTo confirm that the results with the A150P mutation did in fact
report on the conformational properties of the HLA-A2 a2 helix
and were not an artifact themselves, we determined the crystal-
lographic structures of the A150P mutant of HLA-A2 presenting
the Tel1p and the Tax peptides at 2.0 and 2.1 A˚ resolution,
respectively (Table 1). As shown in Figure 4C, the HLA-A2 a2
helix in these structures closely mimics the altered conformation
seen in the A6-Tel1p-HLA-A2 ternary complex, confirming the
conclusions from the binding studies (electron density images
for the helices in these structures are in Figure S6)
Interestingly, in the A150P Tel1p-HLA-A2 structure, there was
weaker electron density for the side chains of Tyr5 and Gln7 of
the Tel1p peptide than in the structure of the wild-type Tel1p-
HLA-A2 complex, despite the two structures being of similar
resolution and quality (Figure 4D, compare with Figure S1). The
electron density for Tyr5 was also weaker than that for Tyr5 in
the A150P Tax-HLA-A2 structure, which crystallized in the
same form as A150P Tel1p-HLA-A2 and even diffracted to
a poorer resolution. The observation of weaker electron density
for the Tel1p side chains when the HLA-A2 a2 helix is shifted
suggests a coupling between the motional properties of the
peptide and the a2 helix when Tel1p but not Tax is bound to890 Immunity 31, 885–896, December 18, 2009 ª2009 Elsevier Inc.HLA-A2 (there were no crystallographic contacts to the peptide
or a2 helix linker region in either of the A150P peptide-HLA-A2
structures). In summary, the data with the A150Pmutant confirm
the shift in the a2 helix upon A6 recognition Tel1p-HLA-A2 and
suggest a linkage between flexibility in the peptide and flexibility
in HLA-A2 when Tel1p but not Tax is bound.
HLA-A2 Possesses Greater Conformational Dynamics
when Tel1p Is Presented as Opposed to Tax
Although the structural and binding data are reminiscent of an
induced-fit mechanism for the conformational change in the
HLA-A2 a2 helix upon TCR recognition of the Tel1p peptide,
a traditional induced-fit mechanism seems unlikely given the
close similarities in the unligated Tax-HLA-A2 and Tel1p-HLA-
A2 complexes (Figure 1). Moreover, emerging data from other
systems suggest that intrinsic dynamics in an unligatedmolecule
can be responsible for conformational changes observed upon
binding (James et al., 2003; Lange et al., 2008; Tobi and Bahar,
2005). To investigate the possibility that flexibility in the unligated
Tel1p-HLA-A2 complex could contribute to the conformational
changes seen upon TCR binding, we examined the dynamical
properties of the Te1p-HLA-A2 a2 helix more closely.
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cysteine. His151 is solvent exposed in the structures of HLA-
A2 with Tax and Tel1p and does not contact any other HLA-A2
side chains. The H151C HLA-A2 mutant was then refolded
with either the Tax or Tel1p peptide and labeled at the free
cysteine with fluorescein-5-maleimide. After repurification, the
steady-state fluorescence anisotropy of the labeled Tax and
Tel1p HLA-A2 complexes was measured. The anisotropy values
of both complexes were in the range of 0.15 to 0.20, similar to the
values reported for fluorescently labeled peptides bound toHLA-
A2 (Binz et al., 2003). However, as shown in Figure 5A, the
steady-state anisotropy of the Tel1p-HLA-A2 complex was
25% lower than that of Tax-HLA-A2. Several control experi-
ments ensured that the difference in anisotropy between the
Tel1p and Tax HLA-A2 complexes could not be attributed to
nonspecific labeling, unincorporated label, or differences in
pMHC stability (see Experimental Procedures).
Loss of anisotropy can occur via three mechanisms: global
tumbling of the protein, rotation of the fluorescent core around
its tether arm, or flexibility of the backbone to which the label is
conjugated. Protein tumbling and rotation of the dye will be the
same in the labeled Tax-HLA-A2 and Tel1p-HLA-A2 complexes,
so the lower anisotropy value for the Tel1p complex indicates
greater dynamics for the a2 helix backbone in the Tel1p complex
compared to the Tax complex.
To ensure that ourmeasurements were properly differentiating
between different degrees of dynamics, we examined a highly
flexible region of HLA-A2. The backbone of Ser195, in a distal
loop at the tip of the HLA-A2 a3 domain, is occasionally disor-
dered in structures with class I pMHC complexes (e.g., Gagnon
et al., 2006). Consistent with this position possessing high
intrinsic dynamics, when labeled with fluorescein, position 195
exhibited a low anisotropy independent of which peptide was
bound (Figure 5A). In addition to serving as a positive controlIfor the dynamics measurements, this observation helps explain
why dynamical differences in the a2 helix linker region were
not evident from comparisons of the Tel1p-HLA-A2 and Tax-
HLA-A2 crystal structures: although the a2 helix linker region is
more dynamic when the Tel1p peptide is bound, it does not
possess the high degree of dynamics characteristic of flexible
loops.
We next examined positions in the peptide binding domain
that are not structurally altered upon A6 recognition of either
Tel1p-HLA-A2 or Tax-HLA-A2. His145 is within the short arm
of the a2 helix and Met138 is at its N-terminal end. The side
chains of both amino acids are solvent exposed and do not
contact atoms of the peptide or HLA-A2 in the unligated Tax-
HLA-A2 or Tel1p-HLA-A2 structures. When cysteine was intro-
duced at these positions and labeledwith fluorescein, the anisot-
ropy was independent of which peptide was bound (Figure 5A),
indicating that the peptide-dependent dynamical differences in
HLA-A2 are localized to the region of the a2 helix that changes
upon A6 recognition of the Tel1p ligand.
Lastly, we repeated the measurements at position 151 by
using BODIPY-FL, a fluorescent tag with a structure different
from that of fluorescein. Again, the anisotropy with the Tel1p
peptide was greater than with the Tax peptide (Figure 5A). The
absolute anisotropy values were lower than observed with fluo-
rescein, attributable to BODIPY-FL’s longer fluorescent lifetime
(6 ns versus 4 ns) and longer tether arm (two additional rotatable
bonds), which allows overall protein tumbling and dye rotation to
have a greater impact in fluorescence depolarization.
To complement the steady-state fluorescence anisotropy
measurements, we next examined the time decay of anisotropy
by using single-photon-counting time-resolved fluorescence
anisotropy (TRFA). In contrast with the steady-state measure-
ments, which measured the anisotropy under constant illumina-
tion, this experiment followed the decay of anisotropy aftermmunity 31, 885–896, December 18, 2009 ª2009 Elsevier Inc. 891
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TCR Cross-reactivity via pMHC Flexibilitya rapid pulse. The advantage of TRFA is that information
regarding motional time scales can be collected. As shown in
Figure 5B, with the fluorescein-labeled samples, the anisotropy
decay in the Tel1p sample was more rapid with Tel1p than
Tax, with 50% of the anisotropy lost by 3.5 ns for Tel1p,
compared to 8.4 ns for Tax. The position 195 control had a
much more rapid decay rate, with 50% of the anisotropy decay
occurring within 1.1 ns. In summary, both the steady-state and
time-resolved fluorescence anisotropy experiments reveal that
the HLA-A2 a2 helix linker region is more mobile when the
Tel1p rather than the Tax peptide is bound.
Free Tel1p-HLA-A2 Samples Its TCR-Bound
Conformation and Possesses Coupled
Peptide-MHC Flexibility
To help interpret the dynamics measurements, we next per-
formed unrestrained molecular dynamics (MD) simulations on
the unligated Tax-HLA-A2 and Tel1p-HLA-A2 complexes. Over
the course of 50 ns of simulation time in explicit solvent, there
were clear differences between the Tax and Tel1p complexes.
In the Tel1p complex, amino acids in the a2 helix linker region
sampled a range of f,c bond angles, including those observed
in the TCR-bound state (Figure 6A). This was most noticeable
for Ala149, which in the Tel1p simulation sampled both the892 Immunity 31, 885–896, December 18, 2009 ª2009 Elsevier Inc.TCR-bound and TCR-free conformations. In contrast, the region
in the Tax simulation was more static. Examining Tyr5 and Gln7
of the Tel1p peptide, these side chains were also found to popu-
late both their TCR-bound and TCR-free conformations
(Figure 6B). These results could not be attributed to peptide
dissociation or unfolding of the peptide binding groove, because
in each simulation the anchoring hydrogen bonds between the
heavy chain and the peptide primary anchors were retained.
We next computed dynamic cross-correlation matrices
(DCCM) for the Tax and Tel1p simulations. The DCCM is com-
posed of coefficients (Cij) describing the time correlation of
motion between components i and j (Ichiye and Karplus, 1991),
in this case the a carbons of the indicated residues. Cij values
range from +1 to 1, with positive values reflecting positively
correlated movement and negative values reflecting anticorre-
lated movement. We focused the analysis on the peptide and
the HLA-A2 a2 helix linker region because the structural data
suggested coupled movement between these two components
in Tel1p-HLA-A2 but not Tax-HLA-A2 (see Figure 4D). In the
Tel1p simulation, the analysis indicated that motion in Tyr5,
Leu6, and Gln7 of the peptide were positively correlated to as
much as 50% with motion in residues 149–155 of the a2 helix
(Figure 6D). In contrast, there was little or no correlated move-
ment between these regions for the Tax simulation. The DCCM
Immunity
TCR Cross-reactivity via pMHC Flexibilitydata therefore revealed a path of dynamic communication
between the peptide and a2 helix in the Tel1p-HLA-A2 complex
but not the Tax-HLA-A2 complex.
Tel1p-HLA-A2 Is of Low Thermal Stability and Is
Recognized by A6 with Disparate Thermodynamics
A prediction from the results of the dynamics experiments with
the Tax and Tel1p complexes with HLA-A2 is that the Tel1p-
HLA-A2 complex should be of lower stability than the Tax-
HLA-A2 complex. We therefore examined the stability of both
complexes by using circular dichroism, monitoring the unfolding
of the HLA-A2 molecule (Figure S7). The apparent Tm of the Tax-
HLA-A2 complex was found to be 64C, in agreement with
previous work (Khan et al., 2000). In contrast, the Tm of the
Tel1p-HLA-A2 complex was lower at 55C. The Tel1p peptide
shares optimal leucine and valine anchor residues with the Tax
peptide, has fully occupied P1, P2, and P9 pockets, and adopts
the usual extended conformation in the HLA-A2 peptide binding
groove, so the lower thermal stability of the Tel1p complex is
best attributed to the greater dynamic instability of the pMHC
complex.
As a final experiment to probe the difference between A6
recognition of the Tax and Tel1p ligands, we determined the
thermodynamics for A6 binding Tel1p-HLA-A2 (Figure S8). The
values for A6 recognition of Tax-HLA-A2 were determined previ-
ously (Davis-Harrison et al., 2005). Under the same conditions
(HEPES buffer [pH 7.4], 25C), recognition of Tel1p-HLA-A2 is
both enthalpically and entropically less favorable than recogni-
tion of Tax-HLA-A2 (DH of 3.0 kcal/mol for Tel1p versus
4.2 kcal/mol for Tax, DS of 9 cal/mol/K for Tel1p versus 12
for Tax). Although different results should be expected from
the two interfaces (Armstrong et al., 2008a), the data are consis-
tent with both the structural and dynamical observations: the
unfavorable shift in enthalpy agrees with the need to stabilize
alternate conformations of the Tel1p peptide and HLA-A2 a2
helix, and the unfavorable shift in entropy agrees with the
binding-associated reduction of conformational dynamics
present in Tel1p-HLA-A2 but not Tax-HLA-A2.
DISCUSSION
Despite serving as a sequence and structural mimic for Tax-
HLA-A2, the Tel1p-HLA-A2 complex forms an unexpectedly
different interface with the A6 TCR, with conformational differ-
ences in the peptide, the HLA-A2 molecule, and the receptor.
The observation is in contrast to other examples of a single
TCR recognizing different peptides presented by the same
MHC molecule (Degano et al., 2000; Garcia et al., 1998; Reiser
et al., 2000, 2003) and is inconsistent with a molecular mimicry
mechanism as traditionally envisioned.
Why is recognition of Tel1p so muchmore complex compared
to recognition of Tax? A conventional explanation would focus
on the small number of steric clashes that occur when the struc-
ture of unligated Tel1p-HLA-A2 is superimposed onto Tax-HLA-
A2 in the A6-Tax-HLA-A2 structure (Figure S4). Yet these clashes
are not extensive and can be remedied by small shifts in side
chain positions. A more crucial observation is that the unbound
Tel1p-HLA-A2 molecule is more dynamic than the Tax-HLA-A2
molecule, and that in Tel1p-HLA-A2, both the peptide and theIHLA-A2 a2 helix at least partially sample their TCR-bound
conformations. These findings suggest a conformational selec-
tion mechanism, whereby the TCR interacts preferentially with
an alternate, binding-competent conformation of the pMHC as
it is sampled (Ma et al., 1999). Conformational selection is
consistent with much emerging data on how flexibility can influ-
ence the specificity of protein-protein interactions (James et al.,
2003; Lange et al., 2008; Tobi and Bahar, 2005). Alternatively, as
enhanced dynamics result from reduced energy barriers sepa-
rating different protein conformations, the conformational
sampling in the unbound molecule could facilitate induced-fit
type changes in the peptide and/or HLA-A2 a2 helix that occur
as binding proceeds. In either case, though, the picture that
emerges is that the ability of A6 to recognize both the Tax and
Tel1p ligands depends at least in part upon the differing degree
of mobility present within the two pMHC complexes.
The influence of peptide flexibility in TCR recognition of pMHC
has been discussed previously. Most related to the results
presented here is the notion that differential peptide flexibility re-
sulting from MHC polymorphisms can broaden TCR reactivity
(Archbold et al., 2009; Fabian et al., 2008; Po¨hlmann et al.,
2004). Our findings extend this concept by showing that not
only can different peptides possess different dynamic character,
but they can also affect the dynamics of the MHC peptide-
binding groove in a way that facilitates TCR engagement.
Thus, TCR recognition, and by extension cross-reactivity, can
be directed by the dynamical character imparted on the ligand
by different peptides.
If differing degrees of ligand flexibility can explain the struc-
tural differences in the peptide and HLA-A2 molecule seen
upon A6 recognition of Tax and Tel1p, what mechanism explains
the different TCR conformations in the two TCR-pMHC inter-
faces? The structure of the A6-Tel1p-HLA-A2 complex is the
sixth ternary complex with A6 showing a different conformation
for CDR3b (Ding et al., 1999; Gagnon et al., 2006; Garboczi et al.,
1996; Piepenbrink et al., 2009), suggesting that the CDR3b loop
possesses its own degree of dynamic instability. This is further
supported by a wealth of binding and mutational data with A6
(Armstrong and Baker, 2007; Davis-Harrison et al., 2005; Laugel
et al., 2005), as well as the general observation that CDR3 loops
in TCRs tend to adopt different conformations free and bound
(Armstrong et al., 2008b). It is thus possible that the conforma-
tion of CDR3b seen in recognition of Tel1p is of equal or even
lower energy than that of the conformation seen in recognition
of Tax. If this is the case, upon recognition of Tel1p, CDR3b
could adopt a more favorable conformation at the expense of
a less favorable Tel1p-HLA-A2 conformation. This option would
not be available for recognition of Tax resulting from the greater
rigidity of the Tax-HLA-A2 complex, forcing the TCR to adopt
a less favorable conformation in order to optimize packing.
This would not fully explain why Tel1p is recognizedmore weakly
than Tax, but other differences between the two interfaces
(such as hydrogen bonding and hydrophobic contacts) will
also influence affinity. Testing this hypothesis, which essentially
describes TCR-pMHC recognition as the cooperative ‘‘melding’’
of two conformational ensembles, will require more detailed
studies of the flexibility of the TCR CDR loops.
Lastly, why is the Tel1p-HLA-A2 complex more dynamic than
the Tax-HLA-A2 complex? Identifying the origins of proteinmmunity 31, 885–896, December 18, 2009 ª2009 Elsevier Inc. 893
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Yet one clue lies in the correlation between movement in the
Tel1p peptide and movement in the HLA-A2 a2 helix observed
both crystallographically and in the molecular simulations. One
interpretation consistent with the data is that rotation of Tyr5
because of thermal fluctuations influences rotation of Gln7
(and vice versa), which together influence the positions of adja-
cent positions in the HLA-A2 a2 helix.
The interpretation above would also explain why the Tax
complex is more rigid than the Tel1p complex. In the unbound
state of either pMHC complex, rotation of the Tyr5 side chain
cannot occur unless other elements of the peptide move out of
the way. In the Tel1p complex this occurs via rotation of the
Tyr5 c bond, followed by a counter-rotation of the Leu6 f
bond to keep the path of the peptide backbone intact. In the
Tax complex, rotation is prevented by the presence of proline
rather than leucine at position 6. Thus the Tax peptide, and by
extension the HLA-A2 a2 helix, remains locked into a smaller
conformational ensemble. This would also explain why observa-
tions similar to ours have not yet been made in other TCR-pMHC
systems, because the relationship between peptide and MHC
dynamics will necessarily be peptide specific. The underlying
phenomenon, that the conformational ensemble of a protein
can be differentially ‘‘tuned’’ by various binding partners, has
been suggested in theoretical studies of protein dynamics and
is compatible with the energy landscape model of protein
conformation and dynamics (Ma et al., 1999; Miller and Dill,
1997).
In conclusion, we have demonstrated that the ability of the
A6 TCR to recognize both the Tax and Tel1p ligands hinges
on the differing degrees of molecular motion present in the
two peptides and the HLA-A2 a2 helix. These results shed
new light on how structural diversity can be presented to
and accommodated by receptors of the immune system and
reveal that antigen-dependent tuning of molecular motion
distributed throughout the TCR binding surface of the pMHC
molecule can contribute to TCR recognition and facilitate
cross-reactivity.EXPERIMENTAL PROCEDURES
Proteins and Peptides
HLA-A2 and the A6 TCR were refolded from bacterially expressed inclusion
bodies and chromatographically purified as previously described (Davis-Har-
rison et al., 2005). Peptides were synthesized locally on an ABI433A instru-
ment; purity and mass were verified by LC-MS. The TCR construct used
included an engineered disulfide bond linking the two constant domains
(Boulter et al., 2003).X-Ray Crystallography
Peptide-HLA-A2 crystals were grown from 24% PEG 3350 in 25 mM MES
(pH 6.5), 0.1 M NaF. A6-Tel1p-HLA-A2 crystals were grown in 15% PEG
4000 in 0.1 M Tris (pH 8.5), 0.2 M MgCl2. Cryoprotection consisted of 20%–
25% glycerol. Diffraction data were collected at Argonne National Laboratory
at the indicated beamlines. Data reduction, structure solution, refinement, and
structure validation was performed as previously described (Gagnon et al.,
2006), with the addition of composite omit maps to evaluate positions in the
models. Composite omit maps, calculated in CNX (Accelrys), iteratively
excluded 5% of the model and included simulated annealing. Search models
for molecular replacement were PDB entries 1TVB for pMHC (Borbulevych
et al., 2005) and 2GJ6 for TCR-pMHC (Gagnon et al., 2006).894 Immunity 31, 885–896, December 18, 2009 ª2009 Elsevier Inc.Surface Plasmon Resonance
Binding experiments were performed with Biacore 3000 and T100 surface
plasmon resonance instruments with the TCR on the sensor surface as previ-
ously described (Davis-Harrison et al., 2005). Measurements were performed
in 20 mM HEPES, 150 mM NaCl, 0.005% P-20 (pH 7.4). All affinities were
measured by steady-state binding measurements, and each injection was
repeated twice. Thermodynamicmeasurements were performed as previously
described (Cole et al., 2009).
Fluorescence Anisotropy
For fluorescent labeling, various amino acids in the HLA-A2 a2 helix linker
region were replaced with cysteine. After normal refolding and purification,
the cysteine mutant pMHC molecules were labeled with fluorescein-5-malei-
mide or BODIPY-FL N-(2-aminoethyl)-maleimide at room temperature for 1
hr. To remove free dye, proteins were first extensively dialyzed against
a 1000-fold buffer excess for 24 hr with three buffer changes. Dialyzed proteins
were then repurified via size-exclusion chromatography, followed by a second
round of dialysis. All labeling reactions were controlled by performing side-by-
side reactions with wild-type pMHC. Nonspecific labeling never reached
above background fluorescence, whereas specific labeling for cysteine
mutants ranged from 70% to 90%. Steady-state fluorescence anisotropy
measurements were performed with a Beacon 2000 instrument (Invitrogen).
Sample conditions were 20 mM sodium phosphate, 75 mM NaCl (pH 7.4).
Labeling, purification, and measurements were repeated three times with
freshly prepared protein. Anisotropy readings on individual samples were
repeated 50 times. The difference in anisotropies between the samples labeled
with fluorescein at position 151 persisted at 4C, 25C, and 37C, persisted in
the presence of 20-fold excess peptide, and was independent of concentra-
tion, from 10 nM to 50 mM. Anisotropy values on both complexes also re-
mained constant during extended incubations at room temperature (up to
48 hr). As a final control to verify the peptide dependence of the anisotropy
and to ensure that free dye did not contribute to the measured values, purified
Tel1p-HLA-A2 fluorescein labeled at position 151was unfolded in 8M urea (pH
10) and separated from free peptide by exhaustive dialysis against denaturant,
and the labeled heavy chain was recovered and refolded with the Tax peptide
and b2m per the usual procedure. The difference in anisotropy measured in
this experiment was identical to that determined from separately labeled
Tel1p-HLA-A2 and Tax-HLA-A2 (see Table S1 for a summary of these control
experiments).
Time-resolved measurements were performed with a FluoroCube 5000U
time-correlated single-photon counting fluorimeter (HORIBA Jobin Yvon)
with a 457 nm NanoLED pulsed excitation source. Sample conditions were
the same as the steady-state measurements, with pMHC concentrations of
3 mM. Experiments were performed at 4C. For each sample, five sets of
measurements were collected that included alternating parallel and perpen-
dicular intensity readings at 30 s intervals; all data were included in the subse-
quent sum/difference anisotropy analysis. Data were processed and analyzed
with the DAS6 software distributed with the instrument.
Circular Dichrosim
Circular dichrosim measurements of thermal stability were performed with an
Aviv 62DS spectrometer monitoring 218 nm as previously described (Khan
et al., 2000). Solution conditions were 20 mM phosphate and 75 mM NaCl
(pH 7.4). Protein concentrations were 10 mM. A temperature increment of
approximately 0.3C/min was used. Because unfolding is irreversible, data
were fit to a six-order polynomial and the apparent Tm taken from the first
derivative of the fitted curve.
Molecular Dynamics Simulations
MD simulations for the Tel1p and Tax complexes with HLA-A2 were performed
with the AMBER9 package (Case et al., 2005). Starting coordinates were from
the secondmolecule in each asymmetric unit. The systems were solvated with
a truncated octahedral box of explicit TIP3Pwater that extended aminimum of
12 A˚ from the solute atoms; crystallographic waters were kept if they were
3.5 A˚ or closer to hydrogen bond donors or acceptors. Sodium cations were
added for neutrality. For equilibration, first the proteins were constrained
whereas surrounding water was optimized. Constraints were then gradually
removed and the entire systems minimized unrestrained. The systems were
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TCR Cross-reactivity via pMHC Flexibilitythen heated to the production temperaturemore than two 50 ps dynamics runs
at constant volume, followed by 1.1 ns of equilibration and then 50 ns of
production at constant pressure. Because the anisotropy experiments
indicated an approximately 25% difference in dynamics, we used a slightly
elevated production temperature of 330K to enhance sampling. Temperature
was controlled with the Langevin scheme. The SHAKE algorithm was used,
allowing a 2 fs time step. Dynamic cross-correlation matrices (DCCM) were
computed with ptraj and visualized with Matlab. Superimpositions for DCCM
calculations were via the backbones of the a1-a2 helices and the peptides.ACCESSION NUMBERS
PDB accession codes for the structures determined in this study are 3H7B for
Tel1p-HLA-A2, 3H9S for A6-Tel1p-HLA-A2, 3H9H for A150P Tel1p-HLA-A2,
and 3IXA for A150P Tax-HLA-A2.SUPPLEMENTAL DATA
Supplemental Data include eight figures and one table and can be
found with this article online at http://www.cell.com/immunity/supplemental/
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